Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.

NCT03783884 is registered in ClinicalTrials.gov with Lungpacer Medical Inc. as lead sponsor.

NCT NCT03783884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03783884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
Lead sponsor
Lungpacer Medical Inc.
Phase
Not applicable
Overall status
Terminated
Start date
June 14, 2019
Completion date
January 27, 2023
Enrollment
223 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

ventilator induced diaphragm dysfunction